FRA:RDC • NL0012044747
The current stock price of RDC.DE is 60.65 EUR. In the past month the price decreased by -3.04%. In the past year, price decreased by -48.12%.
ChartMill assigns a fundamental rating of 3 / 10 to RDC.DE. RDC.DE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months RDC.DE reported a non-GAAP Earnings per Share(EPS) of -1.75. The EPS decreased by -39.61% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.88% | ||
| ROE | -7.01% | ||
| Debt/Equity | 0.62 |
16 analysts have analysed RDC.DE and the average price target is 131.3 EUR. This implies a price increase of 116.49% is expected in the next year compared to the current price of 60.65.
For the next year, analysts expect an EPS growth of 48.65% and a revenue growth 24.2% for RDC.DE
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|
View all stocks in the Drug Retail Industry | View all stocks in the Consumer Staples Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. The company is headquartered in Sevenum, Limburg and currently employs 2,659 full-time employees. The company went IPO on 2016-10-13. The firm focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The firm is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
REDCARE PHARMACY NV
Erik de Rodeweg 11/13
Sevenum LIMBURG NL
Employees: 1827
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. The company is headquartered in Sevenum, Limburg and currently employs 2,659 full-time employees. The company went IPO on 2016-10-13. The firm focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The firm is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
The current stock price of RDC.DE is 60.65 EUR. The price increased by 0.17% in the last trading session.
RDC.DE does not pay a dividend.
RDC.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
16 analysts have analysed RDC.DE and the average price target is 131.3 EUR. This implies a price increase of 116.49% is expected in the next year compared to the current price of 60.65.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on RDC.DE.
REDCARE PHARMACY NV (RDC.DE) has a market capitalization of 1.25B EUR. This makes RDC.DE a Small Cap stock.